Skip to content

GEMI GEMI Funding debt

Funding debt at other companies

Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$340.33M+188%
Affiliated Managers Group logo
Affiliated Managers GroupAMG
$2.92B+11.4%
EnerSys logo
EnerSysENS
$1.08B-0.9%
CNH Industrial N.V. logo
CNH Industrial N.V.CNH
$25.9B-0.4%
Darden Restaurants logo
Darden RestaurantsDRI
$2.14B+0.8%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$11.01B-6.1%

Other financials

Income statement

See full
Revenue$50.3M+42.3%
Operating income-$94.2M-96.1%
Net income-$109.0M+27.0%
EPS (diluted)-$0.93+96.9%

Balance sheet

See full
Cash & equivalents$803.1M+39.1%
Total debt$25.7M
Total equity$456.1M+149%
Total assets$1.5B

Cash flow

See full
Operating cash flow-$54.4M-196%
CapEx$127.0K-32.4%
Free cash flow-$54.6M-193%

Valuation

See full
Market cap$494.35M-87.2%
Enterprise value-$283.08M
P/S2.5×

Profitability

See full
Operating margin-201.4%
Net margin-278.9%
FCF margin-212%

Returns & leverage

See full
Return on equity225%
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by GEMI in its filing.

Tagged under the XBRL concept gemi:FundingDebtIncludingAccruedInterestCurrent.

The official record: GEMI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about GEMI's funding debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GEMI's funding debt?
GEMI (GEMI) reported funding debt of $140.46M in Q1 2026.
What does funding debt mean?
Short-term debt instruments and associated interest used specifically to fund the company's operational activities or lending programs. It reflects the cost and volume of capital borrowed to maintain business momentum.